REMI (Remedent) Operating Margin %: 4.15% (As of Dec. 2020)


REMI Remedent Inc REMI
12 GF Score
Price $0.00
View Full Analysis

What is Remedent Operating Margin %?

Remedent REMI +16.67% 12 Operating Margin % is 4.15% as of Dec. 2020. GuruFocus rates REMI with a GF Score™ of 12/100.

Operating Margin % is calculated as Operating Income divided by its Revenue. Remedent's Operating Income for the three months ended in Dec. 2020 was $0.01 Mil. Remedent's Revenue for the three months ended in Dec. 2020 was $0.34 Mil. Therefore, Remedent's Operating Margin % for the quarter that ended in Dec. 2020 was 4.15%.

The historical rank and industry rank for Remedent's Operating Margin % or its related term are showing as below:


REMI's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.465
* Ranked among companies with meaningful Operating Margin % only.

Remedent's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Remedent's Operating Income for the three months ended in Dec. 2020 was $0.01 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.11 Mil.


Remedent  (OTCPK:REMI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Remedent Operating Margin % Related Terms


Remedent Operating Margin % Historical Data

* Premium members only.

The historical data trend for Remedent's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedent Operating Margin % Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 -45.42 -11.15 -44.70 -45.11

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.95 -77.20 5.02 18.94 4.15

REMI vs SECI, RSCF, OZSC: Operating Margin % Comparison

For the Medical Instruments & Supplies subindustry, Remedent's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remedent Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Remedent's Operating Margin % falls into.


REMI
12GF Score
Remedent Inc REMI
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Remedent Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Remedent's Operating Margin % for the fiscal year that ended in Mar. 2020 is calculated as

Operating Margin %=Operating Income (A: Mar. 2020 ) / Revenue (A: Mar. 2020 )
=-0.48 / 1.064
=-45.11 %

Remedent's Operating Margin % for the quarter that ended in Dec. 2020 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2020 ) / Revenue (Q: Dec. 2020 )
=0.014 / 0.337
=4.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 4.15% mean?
Remedent (REMI) has a Operating Margin % of 4.15% as of Dec. 2020. Operating margin is the ratio of total operating income to net sales. View historical data on Remedent and its competitors.
Is Remedent's Operating Margin % too high?
Remedent's current Operating Margin % is 4.15%. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Remedent's value of 4.15% is 19.8% above this industry median. Overall, Remedent has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Remedent's Operating Margin % compare to SECI and RSCF?
Remedent's Operating Margin % of 4.15% can be compared against companies in the Medical Devices & Instruments industry. The industry median Operating Margin % is 3.47. Remedent's value of 4.15% is 19.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Remedent's current Operating Margin % of 4.15% is 19.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Remedent and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Remedent's current Operating Margin % is 4.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remedent stock overvalued right now?
Remedent (REMI) has a current Operating Margin % of 4.15%. The current Operating Margin % is 4.15% and 19.8% above the Medical Devices & Instruments industry median of 3.47. Remedent's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Remedent (REMI), the current Operating Margin % is 4.15% as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Remedent Business Description

Address Zuiderlaan 1-3, Bus 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
12GF Score

Get the complete analysis for REMI

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price